CAVITATION OF THE GHON FOCUS IN AN HIV-INFECTED INFANT WHO ACQUIRED TUBERCULOSIS AFTER THE INITIATION OF HAART

por Innes, S, Schaaf, H S, Cotton, M F
Publicado 2009

Burden, spectrum, and impact of healthcare-associated infection at a South African children's hospital

por Dramowski, A., Whitelaw, A., Cotton, M.F.
Publicado en J Hosp Infect (2016)

A private organization and public agency partnership in community health education.

por Scarlett, M I, Williams, K R, Cotton, M F
Publicado 1991

COVID-19 response in low- and middle-income countries: Don’t overlook the role of mobile phone communication

por Verhagen, Lilly M., de Groot, R., Lawrence, C.A., Taljaard, J., Cotton, M.F., Rabie, H.
Publicado en Int J Infect Dis (2020)

NeoCLEAN: a multimodal strategy to enhance environmental cleaning in a resource-limited neonatal unit

por Dramowski, A., Aucamp, M., Bekker, A., Pillay, S., Moloto, K., Whitelaw, A. C., Cotton, M. F., Coffin, S.
Publicado en Antimicrob Resist Infect Control (2021)

Pharmacokinetics of Isoniazid in Low-Birth-Weight and Premature Infants

por Bekker, A., Schaaf, H. S., Seifart, H. I., Draper, H. R., Werely, C. J., Cotton, M. F., Hesseling, A. C.
Publicado 2014

Early Antiretroviral Therapy in HIV-Infected Children Is Associated with Diffuse White Matter Structural Abnormality and Corpus Callosum Sparing

por Ackermann, C., Andronikou, S., Saleh, M.G., Laughton, B., Alhamud, A.A., van der Kouwe, A., Kidd, M., Cotton, M.F., Meintjes, E.M.
Publicado en AJNR Am J Neuroradiol (2016)

Early antiretroviral treatment reduces risk of bacille Calmette-Guérin immune reconstitution adenitis

por Rabie, H., Violari, A., Duong, T., Madhi, S. A., Josipovic, D., Innes, S., Dobbels, E., Lazarus, E., Panchia, R., Babiker, A. G., Gibb, D. M., Cotton, M. F.
Publicado 2011

BCG vaccination in South African HIV-exposed infants – risks and benefits

por Hesseling, A C, Caldwell, J, Cotton, M F, Eley, B S, Jaspan, H B, Jennings, K, Marais, B J, Nuttall, J, Rabie, H, Roux, P, Schaaf, H S
Publicado 2009

Dolutegravir as First- or Second-Line Treatment for HIV-1 Infection in Children

por Turkova, A., White, E., Mujuru, H.A., Kekitiinwa, A.R., Kityo, C.M., Violari, A., Lugemwa, A., Cressey, T.R., Musoke, P., Variava, E., Cotton, M.F., Archary, M., Puthanakit, T., Behuhuma, O., Kobbe, R., Welch, S.B., Bwakura-Dangarembizi, M., Amuge, P., Kaudha, E., Barlow-Mosha, L., Makumbi, S., Ramsagar, N., Ngampiyaskul, C., Musoro, G., Atwine, L., Liberty, A., Musiime, V., Bbuye, D., Ahimbisibwe, G.M., Chalermpantmetagul, S., Ali, S., Sarfati, T., Wynne, B., Shakeshaft, C., Colbers, A., Klein, N., Bernays, S., Saïdi, Y., Coelho, A., Grossele, T., Compagnucci, A., Giaquinto, C., Rojo, P., Ford, D., Gibb, D.M.
Publicado en N Engl J Med (2021)